Juan Vera
Vermogen: 540 155 $ op 31-05-2026
Vermogen: 540 155 $ op 31-05-2026
Juan F.
Vera was the founder of AlloVir, Inc., founded in 2013, where the title held was Director & Chief Product Development Officer from 2014 to 2020.
Dr. Vera is also the founder of Marker Cell Therapy, Inc...
Dr. Vera currently holds the positions of President, CEO, Secretary, Treasurer & Director at Marker Therapeutics, Inc. since 2018.
Dr. Vera is also an Associate Professor at Baylor College of Medicine since 2015.
The education history includes a doctorate degree from Universidad El Bosque.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-03-2026 | 344.048 ( 2,06% ) | 540 155 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| MARKER THERAPEUTICS, INC. | Algemeen Directeur | 01-05-2023 |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-01-2004 |
| Bedrijven | Functie | Einde |
|---|---|---|
Marker Cell Therapy, Inc.
Marker Cell Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Develops clinical stage immuno-oncology therapies | Oprichter | - |
| ALLOVIRPAR | Oprichter | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Marker Therapeutics, Inc.
Marker Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cell based immune therapeutics and vaccines for cancer treatment | Health Technology |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AlloVir, Inc.
AlloVir, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies for severe infections | Health Technology |
Marker Cell Therapy, Inc.
Marker Cell Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Develops clinical stage immuno-oncology therapies | Commercial Services |
Universidad El Bosque
Universidad El Bosque Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau